Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Mabpharm Limited ( (HK:2181) ) just unveiled an announcement.
Mabpharm Limited has amended the terms of reference for its Nomination Committee, which is responsible for reviewing the board’s structure, size, and composition, and making recommendations for changes to align with corporate strategy. The committee will also assess the independence of directors, support board performance evaluations, and oversee succession planning for key roles, ensuring the company’s leadership remains effective and compliant with employment terms.
The most recent analyst rating on (HK:2181) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Mabpharm Limited stock, see the HK:2181 Stock Forecast page.
More about Mabpharm Limited
Mabpharm Limited is a company incorporated in the Cayman Islands, operating with limited liability. It is listed under the stock code 2181.
Average Trading Volume: 701,064
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.35B
See more data about 2181 stock on TipRanks’ Stock Analysis page.